Clinical Benefit of 18F-FET in Glioma.
Clinical trial NCT07698457 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07698457
- Sponsor
- Primo Biotechnology Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-01
- Primary completion
- 2027-11-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.